Uses of Rosnacin 1.5 MIU

Rosnacin 1.5 is a drug commonly used in the treatment of infectious diseases. To learn more about the use of the drug as well as instructions for effective use, please refer to the information in the article below.

Rosnacin 1.5 contains the main ingredient is Spiramycin 348.84mg (corresponding to 1.5 M.I.U). This is a drug belonging to the group of Macrolide antibiotics with an antibacterial spectrum similar to Erythromycin, helping to promote high efficiency in bacteriostasis on bacteria that are dividing cells.
Rosnacin's mechanism of action is to prevent bacteria from synthesizing proteins. At low concentrations, the drug has a mainly bacteriostatic effect. However, when high concentrations are achieved, the drug can kill bacteria slowly for sensitive bacteria.

Rosnacin 1.5 is indicated for use in the following cases:
Patients with infections in the respiratory tract, skin and genitals caused by sensitive bacteria. Use in the prophylaxis of meningococcal meningitis when rifampicin is contraindicated. Used in the prophylaxis of congenital Toxoplasma infection in pregnant women. Chemoprophylaxis of recurrent acute rheumatic fever in patients allergic to penicillin. The drug is contraindicated in people who are allergic to Spiramycin, anemia caused by G6PD enzyme deficiency, liver failure, cardiac arrhythmia.

Rosnacin 1.5 is used orally, the appropriate time is at least 2 hours before meals or 3 hours after meals.
Reference dosage when taking Rosnacin 1.5 is as follows:
Basic dosage: Adults: Use at a dose of 1,500,000 - 3,000,000 IU/24 hours, divided into 3 oral doses; Children over 6 years old: Use at a dose of 150,000 IU/kg body weight/24 hours, divided into 3 oral doses. Prophylactic treatment of meningococcal meningitis caused by Meningococcal strains: Adults: Use at a dose of 3,000,000 IU, 2 times/day; Children over 6 years old: Use at a dose of 75,000 IU/kg body weight, 2 times/day, for 5 consecutive days. Prophylaxis of congenital Toxoplasma infection for pregnant women:
Use at a dose of 9,000,000 IU/day, divided into several doses for 3 weeks, 2 weeks apart, repeat dose. Please note that the above dosage is for reference only. The specific dose of the drug will depend on the condition and the progress of the disease, so the patient should consult a doctor or medical professional.

Rosnacin 1.5 rarely causes serious side effects. However, in the process of using the drug, you may still encounter some of the following problems:
Common side effects: Vomiting, nausea, indigestion, diarrhea. Uncommon side effects: Fatigue, nosebleeds, sweating, chest tightness. Patients may also have acute colitis, skin rash, exanthema, urticaria. Rare side effects: Anaphylaxis, superinfection when taking the drug for a long time. In the course of taking the drug, if you see the above signs, the patient should stop using and notify the doctor or go to the nearest medical facility for timely support and treatment.

Rosnacin 1.5 has the potential to interact with some drugs that reduce effectiveness or increase the risk of side effects including:
Concomitant use with oral contraceptives will reduce the effectiveness of preventing pregnancy. Concomitant use with Levodopa will result in a decrease in levodopa plasma concentrations. Concomitant use with Mequitazine will increase the side effects of the drug.

Caution when using Rosnacin 1.5 for people with liver dysfunction because the drug can cause liver toxicity. Use caution when using the drug for people with heart disease, arrhythmias (including people with a tendency to prolong the QT interval) because of the potential for side effects. Patients with glucose - 6 - phosphate - dehydrogenase deficiency may develop hemolytic anemia when taking Rosnacin 1.5 . Above is some information about the drug Rosnacin 1, 5 that readers can refer to. If you have any questions about the dose or use of the drug, you need to contact a specialist for the best advice.